Engineering Graphene for developing Neural Interfaces to revolutionize how we treat neurological diseases

Neurological disorders represent one of the greatest healthcare challenges for our society (1B affected people worldwide). 25-35% of these patients are refractory to pharmacological therapy and are left with no options.

Neuroelectronic therapies, aimed at recording and stimulating brain activity to restore normal brain function, are emerging as a safe alternative for them.

However, current neuroelectronic implants are made of big metal leads with multiple limitations, such as poor resolution, low specificity and high invasiveness.We, at INBRAIN Neuroelectronics, have the solution. We are developing a completed platform of intelligent neuroelectronic interface systems powered by Graphene dots.

We are developing graphene-based neural implants that, powered by AI, will have the capability of reading single neural cells at a resolution never seen before, detecting therapy-specific biomarkers and triggering adaptive responses for increased outcomes in personalized neurological therapies.